Key facts
- Brainreader’s last known valuation is $13.9M (Dec 2021).
- It has raised $12.8M.
- Notable investors include Aarhus University, Bevica Foundation, Dahlgren Capital, Hede Capital Partners, Insero (Other Financial Services) — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Brainreader
- ·The full record, as it builds
Funding rounds
No funding rounds for Brainreader are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Brainreader
Developer of medical image processing software designed to help identify and diagnose neurological diseases in healthcare. The company's software offers MRI scans and provides a self-explanatory patient report with total brain volume, hippocampal volume and volumetric data on key segments of the brain measured against a healthy database, enabling healthcare professionals to get a quantifiable and accurate insight into the brain.
- Sector
- Healthcare
- HQ
- Copenhagen, Denmark
- Founded
- 2011
- Employees
- 13
- Ownership
- Privately Held (backing)
Brainreader doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Brainreader shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Brainreader in its N-PORT filings yet. We sweep new filings monthly.